Lectus Therapeutics' Seed Round

Lectus Therapeutics raised a round of funding on November 14, 2003. Investors include Wyvern Fund.

Lectus Therapeutics is a UK biopharmaceutical company with a proprietary functional proteomics screening platform (LEPTICS), enabling the discovery and development of novel, small molecule modulators …

Articles about Lectus Therapeutics' Seed Round: